language
Language
Englishchevron_right
attach_money
Currency
$USDchevron_right
dark_mode
Dark Mode
policy
Privacy Policy
gavel
Terms of Service
IFFIFF

$70.83

+0.65
arrow_drop_up0.93%
Market closed·update15 Jan 2026 21:00

$70.21

-0.62
arrow_drop_down0.88%
Post-market·update15 Jan 2026 22:22
Day's Range
69.32-71.045
52-week Range
59.14-88.09

Chart

Loading chart...

Performance

Key Stats

Next Earnings Date2025-11-04
Next Earnings TimeAfter Market Close
Volume891.97K
Average Volume 30d2.22M

AI IFF Summary

Powered by LiveAI
💰
25.5
Valuation (P/E Ratio)
Analysis of valuation ratios (Index 24) shows a P/E of 88.1 for 2024 and -7.6 for 2023. The TTM P/E is -19.3 (Index 23). Due to the volatile and negative P/E ratios, a definitive "Reasonable for growth sector" remark is not supported by the provided data. The P/E ratio is highly unstable and often negative, suggesting potential earnings issues or significant one-off events impacting profitability. Further investigation into the reasons for negative earnings is crucial.
📈
0.152
EPS Growth (YoY)
The provided data (Index 11, 25, 28) indicates EPS estimates and reported figures, but not a direct year-over-year EPS growth percentage. For Q2 2025, estimate is 1.14, reported is 1.2. For Q2 2024, estimate was 0.87, reported was 1.13. This shows positive growth, but calculating a precise YoY EPS growth (0.152) is not directly derivable from the provided snapshots. The net income has been negative in 2022 and 2023, making YoY EPS growth calculations challenging and potentially misleading without deeper context.
Show More 🔒

AI Scoreboard

Powered by LiveAI
🔒

Overall Analysis

Buy
78

IFF exhibits solid fundamental strength and a positive outlook driven by its diverse product portfolio. While current technicals indicate some short-term weakness, the long-term growth potential and stable dividend make it an attractive option for growth and income investors.

Positive

Thematic

75

International Flavors & Fragrances (IFF) operates in several growing segments including health, biosciences, and consumer products, benefiting from trends in natural ingredients, functional foods, and sustainable sourcing. Expansion into emerging markets and a focus on innovation contribute to its thematic appeal.

Strong

Fundamental

80

IFF demonstrates a solid financial foundation with consistent revenue generation and a manageable debt level. Recent quarterly results have shown an improvement in net income after a period of losses, indicating a positive turn. The dividend yield provides an income component for investors.

Neutral

Technical

65

The stock is trading below its 50-day and 200-day moving averages, suggesting a prevailing bearish or consolidation trend. Oscillators like RSI and MACD are mixed, indicating a lack of strong momentum in either direction.

FactorScore
Health & Wellness Trends85
Sustainability & Natural Ingredients80
Emerging Markets Growth70
Product Diversification75
Regulatory Landscape65
FactorScore
Valuation60
Profitability30
Growth40
Balance Sheet Health80
Cash Flow75
Dividends85
FactorScore
Trend Analysis30
Momentum50
Volume Analysis70
Support & Resistance70
MACD Indicator50

AI Investing Checklist

Powered by LiveAI
thumb_up

Bullish Points (7)

Earnings Performance chevron_right

Positive EPS Surprises

The company has a track record of exceeding EPS estimates, with positive surprises in 10 out of the last 12 reported quarters. The most recent quarter (2025 Q2) showed a surprise of 5.29% (reported $1.20 vs. estimate $1.14).

Financial Health & Liquidity chevron_right

Improving Debt-to-Equity Ratio

The Debt-to-Equity ratio has shown a declining trend, from 1.3 in 2022Q4 to 0.8 in 2024Q4. This indicates a strengthening balance sheet and reduced financial risk.

Show More 🔒
thumb_down

Bearish Points (7)

Earnings Performance chevron_right

Missed EPS Estimates

The company missed the EPS estimate in the most recent quarter (2024Q4), reporting $0.72 against an estimate of $0.75, indicating potential operational challenges.

Valuation chevron_right

High P/E Ratio on Reported Earnings

The trailing P/E ratio is -19.3 due to recent net losses. The forward P/E (based on estimated earnings for 2025) is not directly available in the provided data, but the historical P/E ratios in 2021 (130.3) and 2024 (88.1) indicate periods of high valuation.

Show More 🔒

Calendar

June 2025

20

Ex-Dividend Date

July 2025

11

Next Dividend Date

August 2025

6

Next Earnings Date

EPS Est.
Revenue Est.

H: $1.15

A: $1.12

L: $1.10

H: 2.78B

A: 2.70B

L: 2.62B

Profile

Websiteiff.com
Employees (FY)22.4K
ISINUS4595061015
FIGI-

International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, pharma solutions, and complementary adjacent products in the United States, Europe, and internationally. It operates in four segments Nourish, Health & Biosciences, Scent, and Pharma Solutions. The Nourish segment consists of portfolio of natural-based ingredients that includes plant-based specialty food ingredients, such as soy and pea protein with value-added formulations, emulsifiers, and sweeteners; food protection ingredients, including natural antioxidants, and anti-microbials for natural food preservation and shelf-life extension; savory solutions, such as spices, marinades, and mixtures; combining flavourings with fruits, vegetables, and other natural ingredients products; a range of flavor compounds used in savory products, such as soups, sauces, meat, fish, poultry, and snacks; and beverages juice drinks, carbonated or flavored beverages, and spirits, as well as sweets bakery products, candy, cereal, and chewing gum; and dairy products, such as yogurt, ice cream, and cheese, as well as spices and seasoning ingredients. Its Health & Biosciences is comprised of health, cultures and food enzymes, home and personal care, animal nutrition, and grain processing. The Scent segment creates fragrance compounds, and fragrance ingredients. Its Pharma Solutions segment produces cellulosics and seaweed-based pharmaceutical excipients. The company was incorporated in 1909 and is headquartered in New York, New York.

Seasonals

2025
2024
2023
2022
2021

Price Target

91.29 USD

The 39 analysts offering 1 year price forecasts for IFF have a max estimate of 110.11 and a min estimate of 73.00.

Debt Level and Coverage

Debt
Free cash flow
Cash & equivalents

Financial Position Analysis

Assets
Liabilities

Ownership

Free Float shares
255M (99.78%)
Closely held shares
565K (0.22%)
256M
Free Float shares
255M (99.78%)
Closely held shares
565K (0.22%)

Capital Structure

Market cap
19.41B
Debt
9.59B
Minority interest
0.00
Cash & equivalents
469M
Enterprise value
28.53B

Valuation - Summary

Market Cap
19.4B
Net income
-1.01B(-5.18%)
Revenue
8.54B(43.99%)
19.4B
Market Cap
19.4B
Net income
-1.01B(-5.18%)
Revenue
8.54B(43.99%)
Price to earning ratio (P/E)-19.30x
Price to sales ratio (P/S)2.30x

Valuation - Ratios

P/E
P/S

Revenue to Profit Conversion

Revenue
11.48B
COGS
7.36B
Gross Profit
4.12B
OpEx
3.28B
Operating Income
848M
Other & Taxes
605M
Net Income
243M

Balance Sheet

Total assets
Total liabilities
Liabilities to assets %

Income Statement

Revenue
Net Income
Net Margin

Cash Flow

Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Show More 🔒